← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2006Last known activity
Jun 30, 2020
Timeline
1980s
- Jan 1, 1985
Davita Clinical Research— Founded
Drugs by trial phase (31 distinct, 27 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (20 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Anthrax
- Catheter-Related Infections
- Chronic Disease
- Communicable Diseases
- Cystic Fibrosis
- Diabetes Mellitus, Type 2
- Hepatic Insufficiency
- Hepatitis
- Hepatitis C
- Hypertension
- Infections
- Influenza, Human
- Kidney Diseases
- Kidney Failure, Chronic
- Liver Diseases
- Liver Failure
- Pruritus
- Renal Insufficiency
- Renal Insufficiency, Chronic
Recent trials (32)
- NCT04428008CollaboratorEarly Phase 1Jun 30, 2020
- NCT03994471Study chairPhase 3Sep 30, 2019
- NCT03791814CollaboratorPhase 4Jan 31, 2019
- NCT03105804CollaboratorN/AMar 29, 2017
- NCT03063034CollaboratorN/AFeb 6, 2017
- NCT03063034Overall official - principal investigatorN/AFeb 6, 2017
- NCT03063047CollaboratorN/AFeb 6, 2017
- NCT03063047Overall official - principal investigatorN/AFeb 6, 2017
- NCT03043482Overall official - principal investigatorPhase 1Jan 24, 2017
- NCT03043482Study directorPhase 1Jan 24, 2017
- NCT02934139Overall official - principal investigatorPhase 1Oct 1, 2016
- NCT02820298Study directorPhase 1Jun 1, 2016
- NCT02651428CollaboratorPhase 3Dec 1, 2015
- NCT02474537Overall official - principal investigatorPhase 1Jun 12, 2015
- NCT02500667CollaboratorPhase 1Jun 1, 2015
Details
- Founded
- Minneapolis, US Jan 1, 1985
- Last known activity
- Jun 30, 2020